Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

Figure 5

Identification of a 24-antibody and cytokine biomarker that differentiates pretreatment etanercept responders from nonresponders. Prediction analysis of microarrays (PAM) was applied to establish a rank list of the variables, by training PAM on all 93 samples. An overlay of error plots derived from PAM analysis of the 93 samples is displayed. First, PAM was trained on the multi-parameter biomarker; blue, training error graph. Second, internal cross-validation of the dataset was performed; red, overall error of the cross-validation. For better readability, error bars are shown for the cross-validation graph only. The number of markers is shown in ascending order from right to left across the top of the panel, and the selected PAM-derived threshold is indicated.

Back to article page